NIKKEI 225
26,651.64 +104.59 (+0.39%) HANG SENG
20,440.25 +490.04 (+2.46%) CRUDE OIL
113.91 -0.29 (-0.25%) GOLD FUTURES
1,826.20 +12.20 (+0.67%) DOW
32,223.42 +26.76 (+0.08%) BTC-GBP
24,641.81 -7.42 (-0.03%)
Equillium, Inc. (0A4D.L)
| Previous close | 3.4900 |
| Open | 2.3220 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.3220 - 2.3220 |
| 52-week range | 2.3220 - 2.3220 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.3510 |
| Earnings date | 22 Mar 2022 - 28 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
LA JOLLA, Calif., May 12, 2022--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the first quarter 2022 and provided an update on its corporate development and clinical programs.
- Business Wire
Equillium Announces Publication of Abstract for the Annual Congress of the European Hematology Association
LA JOLLA, Calif., May 12, 2022--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that the European Hematology Association (EHA) has published an abstract highlighting the Phase 3 EQUATOR study in first-line acute graft-versus-host disease (aGVHD).
- Business Wire
Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists
LA JOLLA, Calif., May 09, 2022--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that three posters were presented over the weekend at IMMUNOLOGY2022, the annual meeting of The American Association of Immunologists. The meetings are taking place at the Oregon Convention Center in Portland, Oregon, May 6 – 10, 2022.
